Bacitracin has 6 known drug interactions based on U.S. FDA drug labeling data. 6 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Cisatracurium Besylate, Pyridostigmine Bromide, Rocuronium. Patients taking Bacitracin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Major
- 6
Major (6)
- Bacitracin + Cisatracurium Besylate— May prolong neuromuscular blockade action of cisatracurium besylate. Use peripheral nerve stimulator and monitor clinica…
- Bacitracin + Pyridostigmine Bromide— Parenteral administration may intensify or produce neuromuscular block and paralysis when used with pyridostigmine.
- Bacitracin + Rocuronium— May enhance neuromuscular blocking action of rocuronium, prolonging neuromuscular block.
- Bacitracin + Rocuronium Bromide— May enhance neuromuscular blocking action of rocuronium bromide, causing prolongation of neuromuscular block.
- Bacitracin + Vancomycin Hydrochloride— Potentially nephrotoxic and neurotoxic drug requiring renal function monitoring when used concurrently with vancomycin.
- Bacitracin + Vecuronium Bromide— Bacitracin may intensify or produce neuromuscular block on its own and can cause unexpected prolongation of vecuronium-i…